Inventor · disambiguated record

Atul Agarwal

Also filed as: AGARWAL ATUL

62 granted patents·11 pending applications·1,339 citations·filing 1999–2024

99Inventor score

Technology areasA61P C07D C07F A61K C07K

Files withACHILLION PHARMACEUTICALS INC60 WYETH CORP4 METABASIS THERAPEUTICS INC3 PHADKE AVINASH2 WYETH LLC2

Top patents by PatentIndex Score

73 records

0199US10822352B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·20 cites·17 claims
0299US10550140B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 4, 2020·27 cites·20 claims
0399US10301336B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·27 cites·20 claims
0499US10287301B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·28 cites·18 claims
0599US10189869B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Jan 29, 2019·27 cites·36 claims
0699US10138225B2Amide compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Nov 27, 2018·33 cites·31 claims
0799US10106563B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·30 cites·20 claims
0899US10100072B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 16, 2018·27 cites·53 claims
0999US10081645B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Sep 25, 2018·27 cites·40 claims
1099US10011612B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jul 3, 2018·30 cites·3 claims
1199US10005802B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 26, 2018·27 cites·38 claims
1299US10000516B2Phosphonate compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 19, 2018·28 cites·28 claims
1399US9828396B2Alkyne compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·30 cites·40 claims
1499US9796741B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Oct 24, 2017·37 cites·50 claims
1599US9758537B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Sep 12, 2017·27 cites·39 claims
1699US9732103B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·32 cites·29 claims
1799US9732104B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·30 cites·68 claims
1899US9695205B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·32 cites·56 claims
1999US9663543B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·32 cites·49 claims
2099US9598446B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·33 cites·7 claims
2198US11708351B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·8 cites·17 claims
2298US11407738B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·16 cites·12 claims
2398US11084800B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·18 cites·11 claims
2498US10919884B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 16, 2021·20 cites·12 claims
2598US10906887B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 2, 2021·20 cites·12 claims
2698US10689409B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jun 23, 2020·9 cites·23 claims
2798US10662175B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·20 claims
2898US10464956B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 5, 2019·21 cites·24 claims
2998US10428095B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 1, 2019·21 cites·2 claims
3098US10428094B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 1, 2019·21 cites·40 claims
3198US10370394B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·23 cites·35 claims
3298US10253053B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Apr 9, 2019·22 cites·20 claims
3398US10087203B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·25 cites·21 claims
3498US6489476B1Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1999·Granted Dec 3, 2002·231 cites·165 claims
3597US12006307B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2022·Granted Jun 11, 2024·3 cites·7 claims
3697US11447465B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·16 cites·8 claims
3797US11053253B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·16 cites·9 claims
3897US11001600B2Disubstituted compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 11, 2021·16 cites·9 claims
3997US10807952B2Compounds for treatment of immune inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·20 cites·13 claims
4097US10660876B2Amino compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·14 claims
4197US7906619B24-amino-4-oxobutanoyl peptides as inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2007·Granted Mar 15, 2011·51 cites·28 claims
4296US12162860B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·2 cites·20 claims
4396US11718626B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Aug 8, 2023·3 cites·21 claims
4496US10092584B2Compounds for the treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Oct 9, 2018·28 cites·41 claims
4595US12139497B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Nov 12, 2024·1 cites·20 claims
4695US11649229B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
4795US11649223B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
4895US10385097B2Ether compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Aug 20, 2019·23 cites·27 claims
4991US12065459B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 20, 2024·3 cites·20 claims
5089US9233136B24-amino-4-oxobutanoyl peptides as inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·9 cites·23 claims

Showing the top 50 of 73 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Atul Agarwal files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →